GAB1 and head and neck squamous cell carcinoma: The results corroborate well with an earlier report wherein, Hoeben et al. showed inhibition of GAB1 activity in head and neck squamous cell carcinoma reduced signaling of EGFR resulting in sensitization of the cells towards gefitinib42.